hypercalcemia
HYPERCALCEMIA
Hypercalcemia is having serum calcium level of >10.5 mg/dL (>2.5 mmol/L).
Mild hypercalcemia is usually asymptomatic. While, more severe hypercalcemia has a constellation of clinical manifestations commonly described as "bones, abdominal moans, stones & groans."
Etiologies may be parathyroid-dependent or parathyroid independent.
Surgery is the treatment of choice for hypercalcemic patients with classic symptoms or complications of primary hyperparathyroidism.

Follow Up

Post-parathyroidectomy Patient

  • Monitor serum & urine Ca to avoid hypo- or hypercalcemia
  • Give Ca supplement for ≥1 year to increase bone density

Primary Hyperparathyroidism Patient Managed Medically

  • Follow up patient every 6 month
  • Measure BP, serum Ca & Cr at each visit
  • Perform yearly abdominal radiographs, urinary Ca & bone mineral density (BMD) tests
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
03 Sep 2018
Dietary nicotinamide riboside (NR) supplementation in 2,000-mg doses daily over a 12-week period is safe, a recent study has shown. However, it does not improve insulin sensitivity and whole-body glucose metabolism in obese, insulin-resistant men.
16 May 2016
Levothyroxine is linked with reduced risk of low birth weight and low Apgar score in pregnant women with subclinical hypothyroidism, a study reported.
02 Jul 2018
Consumption of non-nutritive sweeteners does not appear to contribute to an increase in blood glucose level, a study reports.
13 Apr 2016
Levothyroxine restores reduced circulating fibroblast growth factor 21 (FGF21) levels in overt hypothyroidism patients, as indicated in a study.